Definition, interpretation and calculation of cost-effectiveness acceptability curves

被引:0
作者
Löthgren, M
Zethraeus, N
机构
[1] Stockholm Sch Econ, Ctr Hlth Econ, SE-11383 Stockholm, Sweden
[2] AstraZeneca R&D Sodertalje, Hlth Econ & Outcomes Res, Sodertalje, Sweden
关键词
confidence intervals; cost-effectiveness analysis; cost-effectivenesss acceptability curve; hypothesis testing; net benefit approach;
D O I
10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper discusses the definition, interpretation and computation of cost-effectiveness (CE) acceptability curves. A formal definition of the CE acceptability curve based on the net benefit approach is provided. The curve can be computed using parametric or non-parametric techniques and for both computational approaches we establish a formal relation between the CE acceptability curve and statistical inference based on confidence intervals and P values in CE analysis. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 14 条
[1]  
Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO
[2]  
2-F
[3]  
Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO
[4]  
2-E
[5]  
Chaudhary MA, 1996, STAT MED, V15, P1447
[6]  
EFRON B, 1993, MONOGRAPHYS STAT APP, V57
[7]  
Heitjan DF, 1999, HEALTH ECON, V8, P191, DOI 10.1002/(SICI)1099-1050(199905)8:3<191::AID-HEC409>3.0.CO
[8]  
2-R
[9]   Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy [J].
Obenchain, RL ;
Melfi, CA ;
Croghan, TW ;
Buesching, DP .
PHARMACOECONOMICS, 1997, 11 (05) :464-472
[10]  
RAIKOU K, 1998, BMJ-BRIT MED J, V317, P720